Your Ad Here
PatientsVille.com> Ocrelizumab Report List> Ocrelizumab Side Effects
If You had Ocrelizumab side effect, You are not alone. Other patients reported side effects.
Do You Have Ocrelizumab Side Effects? Enter Your Symptoms:
Use to quickly submit your side effect
Indicate Your Ocrelizumab Side Effects
Ocrelizumab Side Effect (2)
>>See All

Common Ocrelizumab Side Effects

top 5 Ocrelizumab|Ocrelizuma adverse effects>>See All Ocrelizumab Side Effects

Report Detailed Information

Detailed Reporting will help others get complete information and find alternative treatments to avoid or reduce side effects associated with it.

Ask Ocrelizumab Community

Ask patient community about Ocrelizumab related health issues.

View FDA Reports

Ocrelizumab adverse events reported to FDA.

Have You Experienced unusual Ocrelizumab symptoms? PatientsVille.com collects and analyzes Ocrelizumab side effect and adverse reports submitted by Ocrelizumab users, such as .

Summary

FDA Adverse Reports: 5. View All

Ocrelizumab FDA safety alerts: No

Reported deaths: 1

Reported hospitalizations: 4

More About Ocrelizumab

Post Your Unusual Symptoms:

Most Reported
1Ocrelizumab Side Effect
View More
Recent Drug Reports

More Ocrelizumab Side Effect Reports

Questions

Ask a Doctor


13 Doctors are Online Now. Current Wait time: 7 Minutes

blog comments powered by Disqus

Often additional risks of using a medication, such as Ocrelizumab, become known after product is used by a larger number of patients, for a longer period of time, and by patients with different health characteristics from those studied before drug approval. This page allows You to Find answers and discuss health symptoms with other Ocrelizumab users, Learn more about unwanted side effects & find ways to reduce them. Browse Ocrelizumab Adverse Reports reported to FDA and participate in Ocrelizumab discussion, find alternative treatments and find ways to avoid or reduce risks associated with using Ocrelizumab. You can also Post a question to users community or Ask a Doctor. PatientsVille.com is Your Complete Guide to all common, undocumented and undisclosed side effects associated with drugs and vaccines. Browse More Drug Reports Here: A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Search By Drug Names, Symptoms or a Health Condition

Loading

Ocrelizumab Adverse Effect Reports (FDA)

For a quick way to Report Unusual Symptoms, Enter here:

6756297-6 | Cervix Carcinoma
on Aug 07, 2009 Female patient from FRANCE , weighting 145.5 lb, was diagnosed with lupus nephritis and was treated with Ocrelizumab (View Usage). Patient experienced the following unwanted or unexpected effects: cervix carcinoma. Ocrelizumab dosage: Permenantly Discontinued. Last Dose Prior To Sae: 08 October 2008. Dosage Form: Infusion.. During the same period patient was treated with MYCOPHENOLATE MOFETIL (Last Dose Prior To Sae: 20 April 2009. Frequency: Qd (every Day)) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (Dosage Form: Pills. Last Dose Prior To Sae: 20 April 2009. Frequency: Qd (every Day)) (View Prednisone Review and Prednisone Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), SULFATE FERREUX (View Sulfate Ferreux Review and Sulfate Ferreux Label ), CHLORMADINONE ACETATE TAB (View Chlormadinone Acetate Tab Review and Chlormadinone Acetate Tab Label ).

6756296-4 | Neurocryptococcosis
Patient was taking Ocrelizumab (View Usage). Patient had the following side effects: neurocryptococcosis on Apr 22, 2009 from ARGENTINA Additional patient health information: Female patient , weighting 109.8 lb, was diagnosed with lupus nephritis and. Ocrelizumab dosage: Last Dose Prior To Sae: 11 March 2009 Frequency: Day 1- 15 Temporarily Stopped. During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (Date Of Last Dose Prior To Sae: 02 Dec 2008) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6594070-2 | Arthropathy, Hypotension, Joint Range Of Motion Decreased, Postoperative Fever, Tendon Rupture
Adverse event was reported on Feb 18, 2010 by a Female patient taking Ocrelizumab (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , weighting 103.0 lb, After Ocrelizumab was administered, patient had the following side effects: arthropathy, hypotension, joint range of motion decreased, postoperative fever, tendon rupture. During the same period patient was treated with ZOPICLONE (View Zopiclone Review and Zopiclone Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6520432-5 | Arthropathy, Blood Pressure Decreased, Joint Range Of Motion Decreased, Postoperative Fever, Tendon Rupture
on Dec 25, 2009 Female patient from JAPAN , weighting 103.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Ocrelizumab (View Usage). Patient experienced the following unwanted or unexpected effects: arthropathy, blood pressure decreased, joint range of motion decreased, postoperative fever, tendon rupture. Ocrelizumab dosage: . During the same period patient was treated with ZOPICLONE (View Zopiclone Review and Zopiclone Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.


5507151-9 | Obliterative Bronchiolitis, Pulmonary Embolism
on Oct 24, 2007 Male patient from UNITED KINGDOM , weighting 191.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Ocrelizumab (View Usage). Patient had the following side effects: obliterative bronchiolitis, pulmonary embolism (What is pulmonary embolism?). Ocrelizumab dosage: 200 Mg/m2, Q3w. During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CHLORAMBUCIL (View Chlorambucil Review and Chlorambucil Label ), FLUDARABINE PHOSPHATE (Unk, Unk) (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ). Patient was hospitalized and became disabled.


Share Your Experience, Join the Discussion:

Go to the top of the page

Ocrelizumab Questions, Answers, Feedback and Comments

No comments have been provided.

To find out about documented side effects or safety concerns read either the drug label or the drug's package insert. You may also want to speak with your pharmacist or healthcare provider. All medicines have benefits and risks. The risks are the chances that something unwanted or unexpected could happen to you when you use them. You can protect yourself by searching summaries of recent safety alerts, adverse reports. Sometimes there are risks that only come to light after a medical product gets on the market and is used in a larger number of patients, for a longer period of time, and in patients whose health characteristics are different from those of the patients studied before approval.

Be aware of the following potential Ocrelizumab risks to be aware of: 1. Watch for any Serious adverse events, such as life-threatening situation, which can require an admission to hospital or longer-than-expected hospital stay, permanent disability, birth defect, miscarriage, stillbirth, or birth with serious disease requires medical care to prevent permanent damage
2. Any potential Ocrelizumab quality problem: suspected counterfeit product, potentially contaminated product indicated by suspicious odor or unusual color, inaccurate or unreadable product labeling
3. Potential Ocrelizumab use error: mixing up products with similar drug names or packaging, taking wrong dose of a drug because of confusing dosing instructions on label
4. When applicable, Problems with different manufacturer of same medicine: not getting same results from a generic drug as a brand name drug, or from another generic

Go to the top of the page
Go to the top of the page

Mobile version
How Did You Deal with Side Effects?

Report a Drug Side Effect. ... This anonymous Drug Side Effect Survey has 13 questions and takes less than 2 minutes to complete.<<<<

)During the same period patient was treated with OCRELIZUMAB (48 Weeks Under Open-label Ocrelizumab - Last Dose Prior To The Onset Of Sae Was On 09 Feb 2010.) (View ...<<<<

© 2006-2010 Artek LLC | Design by styleshout | Home | Privacy | Terms | About | Contact us PatientsVille.com does not provide medical ...<<<<

A Study of Ocrelizumab in Comparison With ..... Lasix Review and Lasix Label ), COREG (View Coreg Review and Coreg Label ), ASPIRIN (View Aspirin Review and Aspirin ...<<<<

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis. Report a Drug Side Effect. ... This anonymous Drug Side ...<<<<

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis<<<<

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis<<<<

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis<<<<

)During the same period patient was treated with OCRELIZUMAB (Form: Infusion; Form And Frequency Per Protocol; Last Dose Prior To Sae: 19 August 2009; Day 1) (View ...<<<<

> Medical Devices

> Side Effects Wiki

Follow Us on Twitter

Ocrelizumab Reactions
Arthropathy
Blood Pressure Decreased
Cervix Carcinoma
Hypotension
Joint Range Of Motion Decreased
Neurocryptococcosis
Obliterative Bronchiolitis
Postoperative Fever
Pulmonary EmbolismWhat is Pulmonary embolism?
Tendon Rupture
Ocrelizumab Side Effects Notice - The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. PatientsVille.com does not provide medical advice, diagnosis or treatment. The information regarding Ocrelizumab adverse reports, reviews and polls contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments. Thank you for visiting Patientsville.com!